Beyond identification: Emerging and future uses for maldi-tof mass spectrometry in the clinical microbiology laboratory.

Clinics in Laboratory Medicine

Volumn 33, Issue 3, 2013, Pages 611-628

  DeMarco, Mari L ^a   Ford, Bradley A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Antimicrobial susceptibility testing; Bacteremia; Bloodstream infection; Direct identification; Machine learning; MALDI TOF; Mass spectrometry; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BLOOD CULTURE; BLOODSTREAM INFECTION; COMPUTER PROGRAM; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFORMATION PROCESSING; LIMIT OF DETECTION; MACHINE LEARNING; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL IDENTIFICATION; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SPECIES IDENTIFICATION; STRAIN DIFFERENCE; SUPPORT VECTOR MACHINE; TURNAROUND TIME; URINARY TRACT INFECTION; URINE CULTURE;

ANTIMICROBIAL SUSCEPTIBILITY TESTING; BACTEREMIA; BLOODSTREAM INFECTION; DIRECT IDENTIFICATION; MACHINE LEARNING; MALDI-TOF; MASS SPECTROMETRY; URINARY TRACT INFECTION;

BACTEREMIA; BACTERIAL INFECTIONS; BACTERIAL TYPING TECHNIQUES; HUMANS; LABORATORIES; PROTEOMICS; SPECIMEN HANDLING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URINARY TRACT INFECTIONS;

EID: 84881528901     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2013.03.013     Document Type: Review

References (75)

1. van Belkum A., Welker M., Erhard M., et al. Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories. JClin Microbiol 2012, 1(50):1513-1517.
2. Sandrin T.R., Goldstein J.E., Schumaker S. MALDI TOF MS profiling of bacteria at the strain level: a review. Mass Spectrom Rev 2013, 32(3):188-217.
3. Carbonnelle E., Grohs P., Jacquier H., et al. Robustness of two MALDI-TOF mass spectrometry systems for bacterial identification. JMicrobiol Methods 2012, 89:133-136.
4. Benagli C., Rossi V., Dolina M., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of clinically relevant bacteria. PLoS One 2011, 6:e16424.
5. Justesen U.S., Holm A., Knudsen E., et al. Species identification of clinical isolates of anaerobic bacteria: a comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. JClin Microbiol 2011, 1(49):4314-4318.
6. Marko D.C., Saffert R.T., Cunningham S.A., et al. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. JClin Microbiol 2012, 1(50):2034-2039.
7. Rosenvinge F.S., Dzajic E., Knudsen E., et al. Performance of matrix-assisted laser desorption-time of flight mass spectrometry for identification of clinical yeast isolates. Mycoses 2013, 56(3):229-235.
8. Bille E., Dauphin B., Leto J., et al. MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect 2012, 18:1117-1125.
9. Meetani M.A., Voorhees K.J. MALDI mass spectrometry analysis of high molecular weight proteins from whole bacterial cells: pretreatment of samples with surfactants. JAm Soc Mass Spectrom 2005, 16:1422-1426.
10. Williams T.L., Andrzejewski D., Lay J.O., et al. Experimental factors affecting the quality and reproducibility of MALDI TOF mass spectra obtained from whole bacteria cells. JAm Soc Mass Spectrom 2003, 14:342-351.
11. Buchan B.W., Riebe K.M., Ledeboer N.A. Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles. JClin Microbiol 2012, 1(50):346-352.
12. Leibovici L., Shraga I., Drucker M., et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. JIntern Med 1998, 244:379-386.
13. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl 4):S131-S138.
14. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving Sepsis Campaign. Crit Care Med 2013, 41:580-637.
15. Weinstein M.P., Reller L.B., Murphy J.R., et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Clin Infect Dis 1983, 1(5):35-53.
16. Stevenson L.G., Drake S.K., Murray P.R. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2010, 1(48):444-447.
17. Prod'hom G., Bizzini A., Durussel C., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. JClin Microbiol 2010, 48:1481-1483.
18. La Scola B., Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One 2009, 4(11):e8041.
19. Ferroni A., Suarez S., Beretti J.L., et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2010, 48:1542-1548.
20. Marinach-Patrice C., Fekkar A., Atanasova R., et al. Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS One 2010, 5(1):e8862.
21. Meex C., Neuville F., Descy J., et al. Direct identification of bacteria from BacT/ALERT anaerobic positive blood cultures by MALDI-TOF MS: MALDI Sepsityper kit versus an in-house saponin method for bacterial extraction. JMed Microbiol 2012, 61:1511-1516.
22. Fothergill A., Kasinathan V., Hyman J., et al. Rapid identification of bacteria and yeasts from positive BacT/ALERT blood culture bottles by using a lysis-filtration method and MALDI-TOF mass spectrum analysis with SARAMIS database. JClin Microbiol 2013, 51(3):805-809.
23. Croxatto A., Prod'hom G., Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev 2012, 36:380-407.
24. Loonen A.J., Jansz A.R., Stalpers J., et al. An evaluation of three processing methods and the effect of reduced culture times for faster direct identification of pathogens from BacT/ALERT blood cultures by MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2012, 31:1575-1583.
25. Romero-Gómez M.P., Gómez-Gil R., Paño-Pardo J.R., et al. Identification and susceptibility testing of microorganism by direct inoculation from positive blood culture bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective. JInfect 2012, 65:513-520.
26. Szabados F., Michels M., Kaase M., et al. The sensitivity of direct identification from positive BacT/ALERTTM (bioMérieux) blood culture bottles by matrix-assisted laser desorption ionization time-of-flight mass spectrometry is low. Clin Microbiol Infect 2011, 1(17):192-195.
27. Christner M., Rohde H., Wolters M., et al. Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. JClin Microbiol 2010, 48:1584-1591.
28. Qian J., Cutler J.E., Cole R.B., et al. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem 2008, 392:439-449.
29. Reisner B.S., Woods G.L. Times to detection of bacteria and yeasts in BACTEC 9240 blood culture bottles. JClin Microbiol 1999, 37:2024-2026.
30. Lagacé-Wiens P.R., Adam H.J., Karlowsky J.A., et al. Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time. JClin Microbiol 2012, 50:3324-3328.
31. Spanu T., Posteraro B., Fiori B., et al. Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. JClin Microbiol 2012, 50:176-179.
32. Santos C., Paterson R.R., Venâncio A., et al. Filamentous fungal characterizations by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. JAppl Microbiol 2010, 108:375-385.
33. Kwon J.H., Fausone M.K., Du H., et al. Impact of laboratory-reported urine culture colony counts on the diagnosis and treatment of urinary tract infection for hospitalized patients. Am J Clin Pathol 2012, 137:778-784.
34. Ferreira L., Sánchez-Juanes F., González-Avila M., et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2010, 48:2110-2115.
35. Köhling H.L., Bittner A., Müller K.D., et al. Direct identification of bacteria in urine samples by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and relevance of defensins as interfering factors. JMed Microbiol 2012, 61:339-344.
36. DeMarco M.L., Burnham C.D. Direct identification of microbes in urine specimens using mass spectrometry. Clin Chem 2012, 58(S10):A137.
37. Gibb S., Strimmer K. MALDIquant: a versatile R package for the analysis of mass spectrometry data. Bioinformatics 2012, 1(28):2270-2271.
38. Ihaka R., Gentleman R.R. Alanguage for data analysis and graphics. JComput Graph Stat 1996, 5:299-314.
39. Ketterlinus R., Hsieh S.Y., Teng S.H., et al. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques 2005, (Suppl):37-40.
40. Du P., Kibbe W.A., Lin S.M. Improved peak detection in mass spectrum by incorporating continuous wavelet transform-based pattern matching. Bioinformatics 2006, 1(22):2059-2065.
41. Vu T., Valkenborg D., Smets K., et al. An integrated workflow for robust alignment and simplified quantitative analysis of NMR spectrometry data. BMC Bioinformatics 2011, 20(12):405.
42. Chang C.C., Lin C.J. LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol 2011, 2(27):1-27.
43. Chen P., Lu Y., Harrington P.B. Biomarker profiling and reproducibility study of MALDI-MS measurements of Escherichia coli by analysis of variance-principal component analysis. Anal Chem 2008, 1(80):1474-1481.
44. Seibold E., Maier T., Kostrzewa M., et al. Identification of Francisella tularensis by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry: fast, reliable, robust, and cost-effective differentiation on species and subspecies levels. JClin Microbiol 2010, 1(48):1061-1069.
45. Ikryannikova L.N., Filimonova A.V., Malakhova M.V., et al. Discrimination between S.pneumoniae and S. mitis based on sorting of their MALDI mass spectra. Clin Microbiol Infect 2012, [Epub ahead of print]. 10.1111/1469-0691.12113.
46. Barla A., Jurman G., Riccadonna S., et al. Machine learning methods for predictive proteomics. Brief Bioinform 2008, 1(9):119-128.
47. Centor R.M. Signal detectability the use of ROC curves and their analyses. Med Decis Making 1991, 1(11):102-106.
48. Provost F. The case against accuracy estimation for comparing induction algorithms. Proceeding ICML '98 Proceedings of the Fifteenth International Conference on Machine Learning. San Francisco (CA): Morgan Kaufmann Publishers Inc; 1998. p. 445-53.
49. Nantasenamat C., Preeyanon L., Isarankura-Na-Ayudhya C., et al. PyBact: an algorithm for bacterial identification. EXCLI J 2011, 10:240-245.
50. Hall M., Frank E., Holmes G., et al. The WEKA data mining software: an update. SIGKDD Explor Newsl 2009, 11:10-18. Available at:. http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.163.817.
51. Petricoin E.F., Ardekani A.M., Hitt B.A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 16(359):572-577.
52. Check E. Proteomics and cancer: running before we can walk?. Nature 2004, 3(429):496-497.
53. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988, 1(10):S274-S276.
54. Gagnaire J., Dauwalder O., Boisset S., et al. Detection of staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometry. PLoS One 2012, 6:7.
55. De Bruyne K., Slabbinck B., Waegeman W., et al. Bacterial species identification from MALDI-TOF mass spectra through data analysis and machine learning. Syst Appl Microbiol 2011, 34:20-29.
56. Reil M., Erhard M., Kuijper E.J., et al. Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system. Eur J Clin Microbiol Infect Dis 2011, 1(30):1431-1436.
57. Davies A.P., Reid M., Hadfield S.J., et al. Identification of clinical isolates of α-haemolytic streptococci by 16S rRNA gene sequencing, MALDI TOF MS by MALDI Biotyper and conventional phenotypic methods-a comparison. JClin Microbiol 2012, 50(12):4087-4090.
58. Werno A.M., Christner M., Anderson T.P., et al. Differentiation of Streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2012, 1(50):2863-2867.
59. Griffin P.M., Price G.R., Schooneveldt J.M., et al. The use of MALDI-TOF MS to identify vancomycin resistant enterococci and investigate the epidemiology of an outbreak. JClin Microbiol 2012, 50(9):2918-2931.
60. Edwards-Jones V., Claydon M.A., Evason D.J., et al. Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. JMed Microbiol 2000, 1(49):295-300.
61. Jackson K.A., Edwards-Jones V., Sutton C.W., et al. Optimisation of intact cell MALDI method for fingerprinting of methicillin-resistant Staphylococcus aureus. JMicrobiol Methods 2005, 62:273-284.
62. Du Z., Yang R., Guo Z., et al. Identification of staphylococcus aureus and determination of its methicillin resistance by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 2002, 1(74):5487-5491.
63. Wolters M., Rohde H., Maier T., et al. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages. Int J Med Microbiol 2011, 301:64-68.
64. Freiwald A., Sauer S. Phylogenetic classification and identification of bacteria by mass spectrometry. Nat Protoc 2009, 4:732-742.
65. Smole S.C., King L.A., Leopold P.E., et al. Sample preparation of Gram-positive bacteria for identification by matrix assisted laser desorption/ionization time-of-flight. JMicrobiol Methods 2002, 48:107-115.
66. Hrabák J., Chudáčková E., Walková R. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev 2013, 1(26):103-114.
67. Wybo I., Bel A.D., Soetens O., et al. Differentiation of cfiA-negative and cfiA-positive Bacteroides fragilis isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2011, 1(49):1961-1964.
68. Livermore D.M., Woodford N. Carbapenemases: a problem in waiting?. Curr Opin Microbiol 2000, 3:489-495.
69. Podglajen I., Breuil J., Casin I., et al. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. JBacteriol 1995, 1(177):5270-5275.
70. O'Callaghan C.H., Morris A., Kirby S.M., et al. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972, 1(1):283-288.
71. Sparbier K., Schubert S., Weller U., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against B-lactam antibiotics. JClin Microbiol 2012, 1(50):927-937.
72. Burckhardt I., Zimmermann S. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5hours. JClin Microbiol 2011, 1(49):3321-3324.
73. Hrabák J., Walková R., Študentová V., et al. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2011, 1(49):3222-3227.
74. Delcour A.H. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 2009, 1794:808-816.
75. Dunne W.M., Hardin D.J. Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. JClin Microbiol 2005, 1(43):5945-5949.